Profil bibliographique

Nicole Burchardi

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

87Publications signalées

4666Citations signalées

1Affiliations récentes

Les institutions déclarées

German Breast Group

Les domaines associés

Breast Cancer Treatment StudiesCancer Immunotherapy and BiomarkersAdvanced Breast Cancer TherapiesCancer Treatment and PharmacologyCancer Genomics and Diagnostics

Les publications récentes

2023 article OpenAlex

Patient-reported outcomes in high-risk HR+ /HER2- early breast cancer patients treated with endocrine therapy with or without palbociclib within the randomized PENELOPEB study

José Á. García-Sáenz, Frederik Marmé, Michael Untch, Hervé Bonnefoi et autres

es, de, fr, kr, us, au, ca, ie, jp, at, gb (code pays fourni par la source)

6 citations European Journal of Cancer

Accès ouvert 2023 other OpenAlex

Data from Immune-related Gene Expression Predicts Response to Neoadjuvant Chemotherapy but not Additional Benefit from PD-L1 Inhibition in Women with Early Triple-negative Breast Cancer

Bruno V. Sinn, Sibylle Loibl, Claus Hanusch, Dirk-Michael Zahm et autres

0 citations

Accès ouvert 2023 other OpenAlex

Table S2 from Immune-related Gene Expression Predicts Response to Neoadjuvant Chemotherapy but not Additional Benefit from PD-L1 Inhibition in Women with Early Triple-negative Breast Cancer

Bruno V. Sinn, Sibylle Loibl, Claus Hanusch, Dirk-Michael Zahm et autres

0 citations

Accès ouvert 2023 other OpenAlex

Data from Immune-related Gene Expression Predicts Response to Neoadjuvant Chemotherapy but not Additional Benefit from PD-L1 Inhibition in Women with Early Triple-negative Breast Cancer

Bruno V. Sinn, Sibylle Loibl, Claus Hanusch, Dirk-Michael Zahm et autres

0 citations

Accès ouvert 2023 other OpenAlex

Figure S2 from Immune-related Gene Expression Predicts Response to Neoadjuvant Chemotherapy but not Additional Benefit from PD-L1 Inhibition in Women with Early Triple-negative Breast Cancer

Bruno V. Sinn, Sibylle Loibl, Claus Hanusch, Dirk-Michael Zahm et autres

0 citations

Accès ouvert 2023 other OpenAlex

Figure S3 from Immune-related Gene Expression Predicts Response to Neoadjuvant Chemotherapy but not Additional Benefit from PD-L1 Inhibition in Women with Early Triple-negative Breast Cancer

Bruno V. Sinn, Sibylle Loibl, Claus Hanusch, Dirk-Michael Zahm et autres

0 citations

Accès ouvert 2023 other OpenAlex

Figure S1 from Immune-related Gene Expression Predicts Response to Neoadjuvant Chemotherapy but not Additional Benefit from PD-L1 Inhibition in Women with Early Triple-negative Breast Cancer

Bruno V. Sinn, Sibylle Loibl, Claus Hanusch, Dirk-Michael Zahm et autres

0 citations

Accès ouvert 2023 other OpenAlex

Figure S2 from Immune-related Gene Expression Predicts Response to Neoadjuvant Chemotherapy but not Additional Benefit from PD-L1 Inhibition in Women with Early Triple-negative Breast Cancer

Bruno V. Sinn, Sibylle Loibl, Claus Hanusch, Dirk-Michael Zahm et autres

0 citations

Accès ouvert 2023 other OpenAlex

Table S2 from Immune-related Gene Expression Predicts Response to Neoadjuvant Chemotherapy but not Additional Benefit from PD-L1 Inhibition in Women with Early Triple-negative Breast Cancer

Bruno V. Sinn, Sibylle Loibl, Claus Hanusch, Dirk-Michael Zahm et autres

0 citations

Accès ouvert 2023 other OpenAlex

Table S1 from Immune-related Gene Expression Predicts Response to Neoadjuvant Chemotherapy but not Additional Benefit from PD-L1 Inhibition in Women with Early Triple-negative Breast Cancer

Bruno V. Sinn, Sibylle Loibl, Claus Hanusch, Dirk-Michael Zahm et autres

0 citations

Accès ouvert 2023 other OpenAlex

Figure S3 from Immune-related Gene Expression Predicts Response to Neoadjuvant Chemotherapy but not Additional Benefit from PD-L1 Inhibition in Women with Early Triple-negative Breast Cancer

Bruno V. Sinn, Sibylle Loibl, Claus Hanusch, Dirk-Michael Zahm et autres

0 citations

Accès ouvert 2023 other OpenAlex

Figure S1 from Immune-related Gene Expression Predicts Response to Neoadjuvant Chemotherapy but not Additional Benefit from PD-L1 Inhibition in Women with Early Triple-negative Breast Cancer

Bruno V. Sinn, Sibylle Loibl, Claus Hanusch, Dirk-Michael Zahm et autres

0 citations

Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.